
    
      Utapine and Serquel belong to anti-bipolar medication family, both are approved by DOH
      (Department of Health, Taiwan), both has same ingredient but different manufacture. From
      clinical trial reports, both has excellent effectiveness and safety. The goal of this
      research is to evaluate the safety as well as effectiveness of Utapine and Seroquel in
      bipolar I disorder patients for different ingredient and different manufacture.
    
  